The sponsors will use CRF Health's TrialMax® platform to support data capture for quality of life issues during the post-progression phase.
CRF Health, a global provider of eCOA solutions, announced it has agreements with two top tier pharmaceutical companies to support Phase III trials in ovarian and breast cancer. The sponsors will use CRF Health's TrialMax® platform to support data capture for quality of life issues during the post-progression phase. The three studies-two in breast cancer and one in ovarian--will encompass 542 sites, 23 countries and almost 2,000 female trial participants, across the U.S, Europe and Asia Pacific.
Read the full release.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.